Authors : V L Asha Latha, V L Asha Latha, B Sushma, B Sushma, P V G K Sharma, P V G K Sharma
DOI : 10.18231/j.ijcbr.2020.053
Volume : 7
Issue : 2
Year : 2020
Page No : 247-250
Introduction: Staphylococcus aureus (S. aureus) is one of the prominent gram positive human pathogen
secretes many surface and secretary proteins including various enzymes and pathogenic factors that favour
the colonization and infection of host tissue. Alpha-amylase is one of the enzymes secreted by S.aureus
which catalyses the breakdown of complex sugars to monosaccharides, which are required for colonization
and survival of this pathogen.
Materials and Methods: In the present study we have cloned, sequenced, expressed and characterized
a-amylase from the clinical isolate of S.aureus resistant to vancomycin (VRSA). The 25kb plasma DNA
was isolated from the clinical isolate of S.aureus and a 600bp PCR amplified product was obtained.
Results: The SDS-PAGE analysis of induced and un-induced clone SB3 indicates that a-amylase has a
M.W. of 22KD. The ra-amylase was eluted from the gel and enzymes assay was performed. The Km was
found to be close to Km of native a-amylase identified in the extracellular and in the cytosolic fraction of
S.aureus resistant to vancomycin.
Conclusion: The current study clearly indicate that there is clear distinction between the a-amylase of
human and different prokaryotes, particularly S.aureus which made this enzyme an ideal target in the
development of drugs against infections of tooth and oral cavities.
Keywords: Staphylococcus aureus, Alpha-amylase, Cloning, Vancomycin.